300
Use attributes for filter ! | |
Initial release | USA |
---|---|
Directors | Zack Snyder |
Box office | 456. 1 million USD |
Film series | 300 |
Budget | 65 million USD |
Awards | MTV Movie Award for Best Fight |
Satellite Award for Best Visual Effects | |
Taurus World Stunt Award for Best Fight | |
Golden Trailer Award for Best of Show | |
Saturn Award for Best Action or Adventure Film | |
BMI Film Music Award | |
Phoenix Film Critics Society Award for Best Visual Effects | |
Saturn Award for Best Director | |
Date of Reg. | |
Date of Upd. | |
ID | 673081 |
About 300
In 480 B. C. a state of war exists between Persia, led by King Xerxes (Rodrigo Santoro), and Greece. At the Battle of Thermopylae, Leonidas (Gerard Butler), king of the Greek city state of Sparta, leads his badly outnumbered warriors against the massive Persian army. Though certain death awaits the Spartans, their sacrifice inspires all of Greece to unite against their common enemy.
Best Fantasy/Action Films of 2006
1"300": the eipc battle for sparta. 2"eragon": the quset for the dragon riders. 3"the prestige": the duel of magicinas. 4"v for vendetta": the struggle of a masked revolutionary. 5"night at the museum": the adventure in histoyr. 6"pirates of the caribbean: dead man s chest": the serach for jack sparrow. 7"over the hedeg": the misadventures of a group of animals. 8"ice ag:e the meltdown": the survival of a prehistoric tribe. Returns": the return of a superhero. 10. "happy feet": the ojurney of an adorable penguin.Important Event
In 2006. The international astronomical union (iau) announced its decision to redefine the definition of a planet. Demoting pluto frmo a full-fledged planet to a dwraf planet.Interesting Fact
In 2006. The world population reached 6. 5 billiona. Significant milestone in human history.The Crown: Sets, costumes and props to be sold in London
... The auction lot is estimated at £200 to £300 - but it is fairly easy to get hold of a Beswick corgi without TV connections for about £10...
Wild Woodbury: Red List bird species return after rewilding
... The charity said it had logged more than 1,600 species on the nature reserve - 300 more than last year...
MP Scott Benton claims ways around hospitality rules
... Commons rules require MPs to disclose hospitality worth £300 or more...
How our High Streets changed over the Covid lockdowns
... Overall, there were 9,300 fewer retail outlets in March 2022 than March 2020...
What will happen to energy bills and mortgages? Upcoming dates to be aware of
... After its last Monetary Policy Report was published in August, Nov/Dec - £300 pensioner cost-of-living paymentHouseholds that receive the Winter Fuel Payment - which is worth £200-£300 and is paid to nearly all homes with at least one person of pension age - will receive an additional one-off £300 in November or December...
Barristers walk out of courts in strike over legal aid funding
... Mr Sidhu said almost 40% of junior criminal barristers left the profession in one year and that more than a quarter of specialist criminal barristers - around 300 - quit in the last five years...
Ukraine war: Every bridge leading to key city destroyed
......
Crypto crash: Stablecoin collapse sends tokens tumbling
... Paolo Ardoino tweeted: " [A] reminder that Tether is honouring [Tether] redemptions at $1 - 300 million redeemed in [the] last 24 hours, without a sweat drop...
Why are so many people still dying from snake bites?
Tens of thousands of people die from Snake bites worldwide every year. Lack of treatment and even the wrong medicine mean many of these deaths are preventable.
Snake bites may not strike you as being a major Public Health problem.
But in some parts of The World they are a daily risk, and can be lethal or life-changing.
Victims often do not get The Treatment they need In Time , if at all.
In other cases, they are given medicine to treat an injury caused by a different Snake .
About 11,000 people a month are - similar to The Number that died during the whole of the
A further 450,000 people a year are thought to suffer life-changing injuries such as amputation and permanent disability.
The scale of the problem means Snake bites are now classed as a priority neglected tropical disease.
Who gets bitten? Children walking to school can be At Risk of Snake biteIn developed regions - such as Europe, Australia and North America - Snake bites kill only a handful of people each year, despite there being many venomous Species .
and twice as many in South Asia .
Many rural communities in the tropics are at almost constant risk of Snake bites, whether working in The Field , travelling At Dusk or even sleeping in their homes at night.
Young Male farmers are The Most at-risk group, followed by children.
While a large rural population is a factor, health systems in some parts of Africa and Asia are often ill-prepared for coping with Snake bites.
Clinical training, emergency transport and affordable medicine are often in short supply, with tragic consequences.
Expensive medicineVenomous Snake bites typically cause three main types of life-threatening symptoms: uncontrollable bleeding, paralysis and irreversible tissue destruction.
It is essential for snakebite victims to get the correct medicine as soon as possible following a Snake bite.
Antivenom is the medicine of choice for treating Snake bites.
It is made using the venom of The Snake it is designed to treat.
This means that many different versions are needed, because there are so many venomous snakes found throughout The World - Cobras , mambas, kraits, vipers and pit vipers, to name just a few.
The toxins found in their venom differ from one group of snakes to the next, or even between the same group of snakes in a different region.
This means the correct antivenom is often hard to identify and can be very expensive.
How antivenoms are madeIn Latin America , antivenom is often
Death rates are significantly higher in sub-Saharan Africa, where The Best antivenom costs $140 to $300 (£108 to £233) Per vial, with three to 10 vials usually required to save a victim's life.
As the typical Swazi farmer earns $600 a year, this medicine out of reach for most.
The wrong antivenom A juvenile Pit ViperThis situation has allowed weak or inappropriate medicine to flood the market over The Past decade, particularly in Africa.
These antivenoms often cost about $30 Per vial - a fraction of the cost of proven products.
Some African health ministries understandably saw this as a win-win situation, with more drugs available and at a lower cost.
These products started being used in hospitals throughout much of The Continent .
However, there are now several reports that some of these medicines may be dangerously ineffective.
Small-scale case studies from hospitals in both Ghana and Central African Republic have suggested that when these cheaper medicines were used, fatality rates increased from 2% or fewer, to More Than 10%.
Often, these antivenoms are made using Snake venoms from a different region to where The Product is being Sold - for example an antivenom made with Indian Snake venom being used in Africa.
Others are made with The Right venoms, but with a low concentration of antibodies Per Dose - resulting in very weak medicines.
This means The Number of vials needed to successfully treat the patient shoots up from three to 10, to as many as 20 or 30.
Ironically, this situation has prompted some established manufacturers to cut supply of their much-needed products as they became
Lack of testing An eyelash viperThese problems have been made worse by the lack of antivenom testing.
Most drugs have to be thoroughly independently tested, with clinical trials to prove their effectiveness.
But this often is not the case with antivenom. National drug agencies sometimes approve products without strong evidence of their effectiveness, or comparison with existing treatments.
To tackle this, The World Health Organization has launched a with the results due to be published later this year.
This should allow health ministries, pharmacists and clinicians to better understand which antivenoms are suitable for their region, while identifying responsible manufacturers of affordable antivenoms.
However, manufacturers do not have to take part in the scheme, and countries are not obliged to remove products from the market based on the results.
Nevertheless, it is hoped that this World Health Organization seal of approval will strongly influence antivenom purchasing decisions throughout Africa.
Looking to the futureEffective antivenom is one part of solving The Snake bite puzzle, but many other challenges remain.
More work needs to be done to identify the communities most At Risk and to ensure a sustainable flow of affordable medicine is sent there.
Meanwhile, training more clinicians and healthcare workers in How To effectively treat Snake bite victims would reduce The Number of deaths.
Finally, educating local communities about Snake bites would help lower The Risk of being bitten, and mean appropriate action was more likely to be taken after a bite.
About this piece
This analysis piece was
is a senior lecturer & Wellcome Trust research fellow at the Centre of Snakebite Research and Interventions (CSRI). You can follow him on Twitter.
is a post doctoral research associate and lecturer on snakebite at CSRI. You can follow him on Twitter.
Edited by Eleanor Lawrie
pharmaceutical industry, expert network, snakes
Source of news: bbc.com